Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ankur Pandya

Showing results (81-90 of 129) with videos related to

Pageof 13
Sort By:
Cerebrovascular Diseases (Basel, Switzerland)|February 28, 2015
Detection of Symptomatic Carotid Plaque Using Source Data from MR and CT Angiography: A Correlative StudyAjay Gupta, Hediyeh Baradaran, Edward E Mtui, et al.
Annals of Internal Medicine|May 1, 2023
Prioritizing Quality Measures in Acute Stroke Care : A Cost-Effectiveness AnalysisJinyi Zhu, Hooman Kamel, Ajay Gupta, et al.
European Journal of Radiology|June 23, 2022
Neuroimaging in acute ischemic stroke: Trends, disparities, and clinical impactJason J Wang, Jeffrey M Katz, Artem Boltyenkov, et al.
Journal of the American College of Radiology : JACR|January 2, 2021
Cost-Effectiveness Study of Initial Imaging Selection in Acute Ischemic Stroke CareGabriela Martinez, Jeffrey M Katz, Ankur Pandya, et al.
Medrxiv : the Preprint Server for Health Sciences|May 27, 2024
Cost-Effectiveness of Screening Asymptomatic Carotid Stenosis by Atherosclerotic Cardiovascular RiskJinyi Zhu, Janice Jhang, Hanxuan Yu, et al.
American Journal of Hematology|July 4, 2023
Cost-effectiveness of prophylactic emicizumab versus prophylactic recombinant factor VIII in patients with moderate or mild hemophilia A without inhibitors in the United StatesKunal C Potnis, Giri Viswanathan, Robert D Bona, et al.
MDM Policy & Practice|January 19, 2026
Cost-Effectiveness of Risk-Based Screening for Asymptomatic Carotid Artery StenosisJinyi Zhu, Janice Jhang, Hanxuan Yu, et al.
Pharmacoeconomics|March 6, 2026
Component Clinical and Cost Outcomes Complementing Value of Information: Case Study of a Tuberculosis Diagnostics Clinical TrialPamela Pei, Livia Qoshe, Grady Florance, et al.
Blood|June 2, 2026
Haploidentical transplant, gene therapy, and standard care in sickle cell disease: a cost-effectiveness analysisKarthik Chetlapalli, Satoko Ito, Ding Quan Ng, et al.
Journal of the American Heart Association|March 27, 2024
Cost-Effectiveness of Increased Use of Dual Antiplatelet Therapy After High-Risk Transient Ischemic Attack or Minor StrokePaul M Wechsler, Ankur Pandya, Neal S Parikh, et al.
Pageof 13

Showing results (81-90 of 129) with videos related to

Sort By:
Pageof 13
Cerebrovascular Diseases (Basel, Switzerland)|February 28, 2015
Detection of Symptomatic Carotid Plaque Using Source Data from MR and CT Angiography: A Correlative StudyAjay Gupta, Hediyeh Baradaran, Edward E Mtui, et al.
Annals of Internal Medicine|May 1, 2023
Prioritizing Quality Measures in Acute Stroke Care : A Cost-Effectiveness AnalysisJinyi Zhu, Hooman Kamel, Ajay Gupta, et al.
European Journal of Radiology|June 23, 2022
Neuroimaging in acute ischemic stroke: Trends, disparities, and clinical impactJason J Wang, Jeffrey M Katz, Artem Boltyenkov, et al.
Journal of the American College of Radiology : JACR|January 2, 2021
Cost-Effectiveness Study of Initial Imaging Selection in Acute Ischemic Stroke CareGabriela Martinez, Jeffrey M Katz, Ankur Pandya, et al.
Medrxiv : the Preprint Server for Health Sciences|May 27, 2024
Cost-Effectiveness of Screening Asymptomatic Carotid Stenosis by Atherosclerotic Cardiovascular RiskJinyi Zhu, Janice Jhang, Hanxuan Yu, et al.
American Journal of Hematology|July 4, 2023
Cost-effectiveness of prophylactic emicizumab versus prophylactic recombinant factor VIII in patients with moderate or mild hemophilia A without inhibitors in the United StatesKunal C Potnis, Giri Viswanathan, Robert D Bona, et al.
MDM Policy & Practice|January 19, 2026
Cost-Effectiveness of Risk-Based Screening for Asymptomatic Carotid Artery StenosisJinyi Zhu, Janice Jhang, Hanxuan Yu, et al.
Pharmacoeconomics|March 6, 2026
Component Clinical and Cost Outcomes Complementing Value of Information: Case Study of a Tuberculosis Diagnostics Clinical TrialPamela Pei, Livia Qoshe, Grady Florance, et al.
Blood|June 2, 2026
Haploidentical transplant, gene therapy, and standard care in sickle cell disease: a cost-effectiveness analysisKarthik Chetlapalli, Satoko Ito, Ding Quan Ng, et al.
Journal of the American Heart Association|March 27, 2024
Cost-Effectiveness of Increased Use of Dual Antiplatelet Therapy After High-Risk Transient Ischemic Attack or Minor StrokePaul M Wechsler, Ankur Pandya, Neal S Parikh, et al.
Pageof 13